BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $443,626 | -14.6% | 18,446 | +13.4% | 0.00% | 0.0% |
| Q2 2023 | $519,437 | +3.9% | 16,268 | -0.4% | 0.00% | 0.0% |
| Q1 2023 | $500,178 | -19.5% | 16,335 | +2.9% | 0.00% | -33.3% |
| Q4 2022 | $621,106 | -14.7% | 15,881 | +4.0% | 0.01% | -25.0% |
| Q3 2022 | $728,000 | +27.3% | 15,276 | +3.4% | 0.01% | +33.3% |
| Q2 2022 | $572,000 | +8.3% | 14,772 | +60.4% | 0.01% | +50.0% |
| Q1 2022 | $528,000 | -25.8% | 9,209 | +3.1% | 0.00% | -20.0% |
| Q4 2021 | $712,000 | -4.0% | 8,929 | +4.8% | 0.01% | -16.7% |
| Q3 2021 | $742,000 | -30.7% | 8,523 | +2.4% | 0.01% | -33.3% |
| Q2 2021 | $1,071,000 | +164.4% | 8,320 | +64.4% | 0.01% | +125.0% |
| Q1 2021 | $405,000 | +0.7% | 5,062 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $402,000 | – | 4,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |